Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for amphotericin root_notes_note in Note (approximate match)

Showing 1891 - 1900 of 2111 results

First page
Previous page
Next page
Next page

INFLUENZA B VIRUS B/HUBEI-WUJIAGANG/158/2009 BX-39 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

N9Y20GQG1J

Status:

Discontinued

Source:

BLA125127

Source URL:

https://www.drugbank.ca/drugs/DB14610

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/TEXAS/6/2011 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

P1QC15R40T

Status:

Discontinued

Source:

BLA103914

Source URL:

https://www.drugbank.ca/drugs/DB14451

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/BRISBANE/60/2008 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

166D8OWM7B

Status:

Discontinued

Source:

BLA103914

Source URL:

https://www.drugbank.ca/drugs/DB10794

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/BRISBANE/60/2008 HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

X1415B53PG

Status:

Discontinued

Source:

BLA125163

Source URL:

https://www.drugbank.ca/drugs/DB14439

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/BRISBANE/60/2008 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

45E2IPU4MG

Status:

Discontinued

Source:

BLA125254

Source URL:

https://www.drugbank.ca/drugs/DB11044

Class:

STRUCTURALLY DIVERSE

PM-HAdV3 (Pool of 234 peptides derived from a peptide scan (15mers with 11 aa overlap) through Hexon protein of Human Adenovirus (HAdV) - type B serotype 3)

J4MA6E23JR

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

HAdV-5 (penton protein) Pool of 140 peptides derived from a peptide scan (15mers with 11 aa overlap) through Penton protein of Human Adenovirus (HAdV) - type B serotype 5.

MH8T3997YU

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B

HZJ2V81RYU

Status:

Possibly Marketed Outside US

Source:

ANDA075679

(2003)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=198a4140-f4c0-4478-9157-ee1d68d0bb96

First approved in 2003

Source:

ANDA075679

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=198a4140-f4c0-4478-9157-ee1d68d0bb96

Class:

G1 SPECIFIED SUBSTANCE

HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN

LUY6P8763W

Status:

US Approved Rx (1989)

Source:

BLA103237

(1989)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1989

Source:

BLA103237

Source URL:

https://www.fda.gov/media/113210/download

Class:

CONCEPT

(2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-methoxy-7,9-dioxo-2,5-methanopyrido[1?,2?:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid

RD7MNM79RD

Status:

Other

Class:

CONCEPT

Structurally Diverse

INFLUENZA B VIRUS B/HUBEI-WUJIAGANG/158/2009 BX-39 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/TEXAS/6/2011 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/BRISBANE/60/2008 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/BRISBANE/60/2008 HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/BRISBANE/60/2008 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

J4MA6E23JR
Not a public record

Concept

PM-HAdV3 (Pool of 234 peptides derived from a peptide scan (15mers with 11 aa overlap) through Hexon protein of Human Adenovirus (HAdV) - type B serotype 3)

Concept

HAdV-5 (penton protein) Pool of 140 peptides derived from a peptide scan (15mers with 11 aa overlap) through Penton protein of Human Adenovirus (HAdV) - type B serotype 5.

HZJ2V81RYU
Not a public record

Concept

ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B

Concept

HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN

Concept

(2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-methoxy-7,9-dioxo-2,5-methanopyrido[1?,2?:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid

Showing 1891 - 1900 of 2111 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1